Alexion Pharmaceuticals, Inc.

About Alexion Pharmaceuticals, Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening ultra-rare disorders. In addition, Alexion’s metabolic franchise includes two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). Alexion is advancing the most robust rare disease pipeline in the biotech industry with highly innovative product candidates in multiple therapeutic areas.


Software Development Intern

June 2020 - September 2020 New Haven, CT
“I liked that Alexion Pharmaceuticals did a great job of transitioning their internship to a remote environment.”

Corporate Accounting Intern

June 2019 - August 2019 New Haven, CT
“I enjoyed the members of the team I worked with an gaining practical experience in my field. ”
See All